Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Integrative clinical and preclinical studies identify Fer... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH
0
Authors
Liang Tao
18 more
Liang Tao
•
Ming‐Hua Zheng
16 more
•
Fudi Wang
Published
August 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Cell Metabolism
Topics
Biology
Bioinformatics
Medicine
Biochemistry
Cancer Oncology
Show all topics
DOI
10.1016/j.cmet.2024.07.013
License
CC-BY
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Cell Metabolism
Topics
Biology
Bioinformatics
Medicine
Biochemistry
Cancer Oncology
Show all topics
DOI
10.1016/j.cmet.2024.07.013
License
CC-BY
